Innovator Spotlight : C2-Ai
As well as helping UK HealthTech innovators gain access to the NHS market , we can also support them with their international export aspirations . We spoke to Richard Jones , President and Chief Operating Officer at C2-Ai about how , through our partnerships with the Association of British HealthTech Industries ( ABHI ) and the Department for Business and Trade ( DBT ), we provide opportunities for companies like them who are ready for export to attend trade missions in the USA , Middle East and China .
Copeland Clinical Ai ( C2-Ai ), a multiaward-winning healthcare analytics and AI company , develops artificial intelligence-powered tools to help hospitals reduce avoidable harm and mortality , save lives , and make significant savings on operating expenditure ( potentially millions per hospital ).
In the UK , C2-Ai is focused on the prioritisation of the elective waiting list , ensuring that patients are risk stratified on their individual clinical need .
The company ’ s technology was named among the 10 essential digital health ideas for a UK COVID-19 national response by Healthcare UK ( part of the Department for International Trade ) for its ability to help predict avoidable harm and mortality and
22 Transforming Lives Through Innovation